Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eledon Pharmaceuticals (ELDN) Operating Expenses (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Operating Expenses readings, the most recent being $2.1 million for Q4 2017.

  • On a quarterly basis, Operating Expenses rose 43.49% to $2.1 million in Q4 2017 year-over-year; TTM through Dec 2017 was $13.1 million, a 15.33% decrease, with the full-year FY2025 number at $7.5 million, up 14.23% from a year prior.
  • Operating Expenses hit $2.1 million in Q4 2017 for Eledon Pharmaceuticals, down from $3.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $13.3 million in Q1 2015 to a low of $932000.0 in Q2 2016.
  • Median Operating Expenses over the past 5 years was $5.7 million (2013), compared with a mean of $5.9 million.
  • Biggest five-year swings in Operating Expenses: crashed 89.62% in 2016 and later surged 615.24% in 2017.
  • Eledon Pharmaceuticals' Operating Expenses stood at $5.5 million in 2013, then grew by 12.83% to $6.3 million in 2014, then surged by 76.84% to $11.1 million in 2015, then plummeted by 86.75% to $1.5 million in 2016, then skyrocketed by 43.49% to $2.1 million in 2017.
  • The last three reported values for Operating Expenses were $2.1 million (Q4 2017), $3.0 million (Q3 2017), and $6.7 million (Q2 2017) per Business Quant data.